Rafael Holdings Inc

Company Profile

• Business description

  Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

• Contact

  520 Broad Street
  NewarkNJ07102
  USA

  T: +1 212 658-1450

  E: [email protected]

  https://www.rafaelholdings.com

• Sector

  Real Estate

  Stock type

  Cyclical

• Industry

  Real Estate Services

  Fiscal Year End

  31 July 2025

  Employees

  31